PD‐1/L1 inhibitors can improve but not replace chemotherapy for advanced urothelial carcinoma: A systematic review and network meta‐analysis

PD‐1/L1 inhibitors can improve but not replace chemotherapy for advanced urothelial carcinoma: A systematic review and network meta‐analysis

Abstract Background Programmed cell death‐1/ligand 1 inhibitors are a new treatment strategy for advanced urothelial carcinoma. Therefore, a comparative evaluation of their efficacy and toxicity compared with chemotherapy is necessary. Methods We comprehensively searched PubMed, Web of Science, Emba...

Full description

Bibliographic Details
Main Authors: Longkun Mao, Meihua Yang, Xinxiang Fan, Wenjie Li, Xiaodong Huang, Wang He, Tianxin Lin, Jian Huang
Format: Article
Language:English
Published: Wiley 2023-06-01
Series:Cancer Innovation
Subjects:
chemotherapy
efficacy
immune checkpoint inhibitors
safety
urinary bladder neoplasms
Online Access:https://doi.org/10.1002/cai2.75

Internet

https://doi.org/10.1002/cai2.75

Similar Items